What is Opko Health's D&A?

Opko Health (OPK) reported D&A of $22.2M in Q1 2026.

How has Opko Health's D&A changed year-over-year?

Opko Health's D&A decreased by 5.5% year-over-year, from $23.49M to $22.2M.

What is the long-term trend for Opko Health's D&A?

Over 4 years (2021 to 2025), Opko Health's D&A has grown at a 3.9% compound annual growth rate (CAGR), from $78.72M to $91.63M.

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

Opko Health OPK D&A

D&A at other companies

Quest DiagnosticsDGX

$147M+5.0%

Olema Pharmaceuticals, Inc.OLMA

$119K-7.0%

HRO

HarrowHROW

$455K-2.2%

PrecigenPGEN

$1.1M+74.7%

ImmunomeIMNM

$603K-1.3%

Ultragenyx PharmaceuticalRARE

$8M-11.1%

Segments

By segment

See full

Pharmaceutical$18.26M+2.7%

Diagnostics$3.93M-31.1%

Other financials

Income statement

See full

Revenue$124.2M-17.2%

Gross profit$45.8M+7.4%

Operating income-$51.0M+24.0%

Net income-$54.8M+18.9%

EPS (diluted)-$0.07+30.0%

Balance sheet

See full

Cash & equivalents$40.6M-62.5%

Total debt$52.8M-4.2%

Total equity$1.2B-8.2%

Total assets$1.9B-12.8%

Cash flow

See full

Operating cash flow-$19.3M+44.1%

CapEx$1.8M-42.6%

Free cash flow-$21.1M+44.0%

Valuation

See full

Market cap$1.13B-22.4%

P/S1.9×-0.2×

Profitability

See full

Gross margin36%+4.2pp

Operating margin-17.4%-5.6pp

Net margin-36.6%-44.8pp

FCF margin-30%+0.1pp

Returns & leverage

See full

Return on equity-16.9%-21.7pp

Debt / equity0×0.0×

Current ratio3.6×+1.1×

Where this comes from

Reported directly by Opko Health in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: Opko Health’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opko Health's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Opko Health's D&A?: Opko Health (OPK) reported D&A of $22.2M in Q1 2026.
How has Opko Health's D&A changed year-over-year?: Opko Health's D&A decreased by 5.5% year-over-year, from $23.49M to $22.2M.
What is the long-term trend for Opko Health's D&A?: Over 4 years (2021 to 2025), Opko Health's D&A has grown at a 3.9% compound annual growth rate (CAGR), from $78.72M to $91.63M.
What does D&A mean?: Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.